Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-04

FDA Approved: FESOTERODINE FUMARATE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for Amneal's fesoterodine fumarate, a generic version of the overactive bladder medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fesoterodine fumarate (fesoterodine fumarate)

Snippet

SUPPL AP for FESOTERODINE FUMARATE (FESOTERODINE FUMARATE)